Literature DB >> 24321028

Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation.

Helen Mactier1, Deborah Shipton, Carol Dryden, David M Tappin.   

Abstract

AIM: To determine if reduced fetal growth in infants of opioid-dependent mothers prescribed methadone maintenance in pregnancy is explained by cigarette smoking or socio-economic deprivation.
DESIGN: Retrospective cohort study.
SETTING: Inner-city maternity unit in Scotland. PARTICIPANTS: A total of 366 singleton infants of methadone-prescribed opioid-dependent mothers compared with the Scottish birth population (n=103 366) as a whole. MEASUREMENTS: Primary outcome measures were birth weight and head circumference.
FINDINGS: In infants of methadone-prescribed opioid-dependent mothers mean birth weight was 259 g [95% confidence interval (CI) 214-303 g; P<0.0001] less, and mean head circumference 1.01 cm (95% CI 0.87-1.15 cm; P<0.0001) less than in controls, allowing for gestation, cigarette smoking, area deprivation, infant sex and maternal age and parity. This represents an adjusted difference of -0.61 (95% CI -0.52--0.71; P<0.0001) Z-score in mean birth weight and -0.77 (95% CI -0.66--0.89; P<0.0001) Z-score in mean head circumference.
CONCLUSIONS: Reduced fetal growth in infants of opioid-dependent mothers prescribed methadone maintenance in pregnancy is not fully explained by cigarette smoking, area deprivation, maternal age or parity.
© 2013 Society for the Study of Addiction.

Entities:  

Keywords:  Fetal growth; head growth; methadone; neonatal; pregnancy; substance misuse

Mesh:

Substances:

Year:  2013        PMID: 24321028     DOI: 10.1111/add.12400

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

3.  Commentary on Mactier et al. (2014): Methadone-assisted treatment and the complexity of influences on fetal development.

Authors:  Hendrée E Jones; Mishka Terplan; Catherine J Friedman; James Walsh; Lauren M Jansson
Journal:  Addiction       Date:  2014-03       Impact factor: 6.526

4.  Prenatal methadone exposure is associated with altered neonatal brain development.

Authors:  Victoria J Monnelly; Devasuda Anblagan; Alan Quigley; Manuel Blesa Cabez; E Sarah Cooper; Helen Mactier; Scott I Semple; Mark E Bastin; James P Boardman
Journal:  Neuroimage Clin       Date:  2017-12-24       Impact factor: 4.881

5.  Sex Differences in Early Cognitive Development After Prenatal Exposure to Opioids.

Authors:  Martine Skumlien; Inge Olga Ibsen; Ulrik Schiøler Kesmodel; Egil Nygaard
Journal:  J Pediatr Psychol       Date:  2020-06-01

6.  Behavior and Attention Problems in Eight-Year-Old Children with Prenatal Opiate and Poly-Substance Exposure: A Longitudinal Study.

Authors:  Egil Nygaard; Kari Slinning; Vibeke Moe; Kristine B Walhovd
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

7.  Evaluation of the vaginal flora in pregnant women receiving opioid maintenance therapy: a matched case-control study.

Authors:  Alex Farr; Herbert Kiss; Michael Hagmann; Iris Holzer; Verena Kueronya; Peter W Husslein; Ljubomir Petricevic
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-05       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.